Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plant-derived pharmaceuticals--the road forward.

Julian K-C Ma1, Rachel Chikwamba, Penny Sparrow

  • 1Department of Cellular and Molecular Medicine, St. George's Hospital Medical School, Cranmer Terrace, London, UK SW17 0RE. jma@sgul.ac.uk

Trends in Plant Science
|November 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering Secretory (S)IgA to Facilitate Affinity Purification for Large Scale Downstream Processing.

Biotechnology journal·2026
Same author

Production of the High Value Pharmaceutical Target, Human Granulocyte-Colony Stimulating Factor, in Nicotiana benthamiana Is Improved by Co-Expression of the Transcriptional Regulator of the Unfolded Protein Response, bZIP60.

Plant biotechnology journal·2026
Same author

From farm to bedside: Potential of medical cannabis in global health.

Complementary therapies in medicine·2025
Same author

Characterisation of chikungunya virus neutralising monoclonal antibodies expressed in tobacco plants.

Journal of biotechnology·2025
Same author

Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination.

Vaccine·2025
Same author

Corrigendum: Transient proteolysis reduction of <i>Nicotiana benthamiana</i>-produced CAP256 broadly neutralizing antibodies using CRISPR/Cas9.

Frontiers in plant science·2025

Plant-derived pharmaceuticals offer scalable, affordable drug production, especially for developing nations. However, regulatory hurdles and intellectual property rights present significant commercialization challenges.

Area of Science:

  • Biotechnology
  • Pharmaceutical Sciences
  • Agricultural Science

Background:

  • Plant-derived pharmaceuticals present a promising avenue for large-scale, economical drug and vaccine production.
  • These systems offer advantages in product safety, storage, and distribution compared to conventional methods.
  • They hold significant potential for supplying low-cost medicines to developing countries.

Purpose of the Study:

  • To highlight the commercialization potential of plant-derived pharmaceuticals.
  • To identify key challenges in the regulatory and intellectual property landscapes.
  • To assess the feasibility of adapting Good Manufacturing Practice (GMP) regulations for field-grown pharmaceutical plants.

Main Methods:

  • Review of current biotechnological production systems for pharmaceuticals.

Related Experiment Videos

  • Analysis of regulatory frameworks for pharmaceutical manufacturing.
  • Examination of intellectual property (IP) laws and licensing requirements for global drug development.

    • Main Results:

    • Plant-based systems offer unparalleled production scale and economic benefits.
    • Significant regulatory uncertainties exist, particularly concerning GMP for field cultivation.
    • Intellectual property negotiations, including freedom-to-operate licenses, are critical for market access.

    Conclusions:

    • Plant-derived pharmaceuticals are a viable and advantageous production system.
    • Successful commercialization hinges on navigating complex regulatory and IP challenges.
    • Addressing these hurdles is essential for realizing the global health benefits of plant-made pharmaceuticals.